Myron J. Levin mainly focuses on Immunology, Vaccination, Virus, Internal medicine and Virology. Myron J. Levin interconnects Zoster vaccine, Antibody titer, Guideline, Intensive care medicine and Postherpetic neuralgia in the investigation of issues within Vaccination. His work in Zoster vaccine tackles topics such as Vaccine efficacy which are related to areas like Herpes Zoster Vaccine.
His studies in Virus integrate themes in fields like Molecular biology, Growth inhibition and Toxicity. He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Placebo and, in certain cases, Adverse effect, Clinical trial, Lesion, Chemotherapy regimen and Chemotherapy. Myron J. Levin combines subjects such as Mucocutaneous zone, Host and Immunogenicity with his study of Virology.
His primary areas of investigation include Immunology, Virology, Virus, Vaccination and Varicella zoster virus. His Virology course of study focuses on Antigen and Peripheral blood mononuclear cell. In his study, RNA and DNA is strongly linked to Molecular biology, which falls under the umbrella field of Virus.
His Vaccination research is multidisciplinary, incorporating perspectives in Zoster vaccine, Herpes Zoster Vaccine, Pediatrics and Immunization. In his research on the topic of Herpes Zoster Vaccine, Neuralgia is strongly related with Postherpetic neuralgia. His Varicella zoster virus study integrates concerns from other disciplines, such as Cellular immunity and Chickenpox.
His primary scientific interests are in Immunology, Zoster vaccine, Vaccination, Virology and Pediatrics. Myron J. Levin has included themes like Internal medicine, Quality of life and Immunization, Reactogenicity in his Zoster vaccine study. His research in Internal medicine focuses on subjects like Vaccine efficacy, which are connected to Postherpetic neuralgia.
His Vaccination research is multidisciplinary, incorporating elements of Shingles, Herpes Zoster Vaccine, Titer, Antibody titer and Immunity. His studies link Protein subunit with Virology. His Pediatrics study incorporates themes from Surgery, Incidence, Cohort study, Varicella zoster immune globulin and Claims data.
The scientist’s investigation covers issues in Vaccination, Immunology, Internal medicine, Herpes Zoster Vaccine and Zoster vaccine. Virology covers he research in Vaccination. His work on Varicella zoster virus, Immunogenicity and Adjuvant as part of his general Immunology study is frequently connected to Polyomavirus Infections, thereby bridging the divide between different branches of science.
His Internal medicine research incorporates elements of Placebo and Vaccine efficacy. The various areas that he examines in his Zoster vaccine study include Phase iii trials and Quality of life. In his work, Immunity and Virus is strongly intertwined with Antibody, which is a subfield of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader.
The New England Journal of Medicine (2005)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin;Myron J. Levin;Per Ljungman;E. Graham Davies.
Clinical Infectious Diseases (2014)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal;Anthony L. Cunningham;Olivier Godeaux;Roman Chlibek.
The New England Journal of Medicine (2015)
Recommendations for the management of herpes zoster.
Robert H. Dworkin;Robert W. Johnson;Judith Breuer;John W. Gnann;John W. Gnann.
Clinical Infectious Diseases (2007)
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin;Myron J. Levin;Per Ljungman;Per Ljungman;E. Graham Davies.
Clinical Infectious Diseases (2014)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham;H. Lal;M. Kovac;R. Chlibek.
The New England Journal of Medicine (2016)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston.
Annals of Internal Medicine (2002)
Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy
Teresa H. Bacon;Myron J. Levin;Jeffry J. Leary;Robert T. Sarisky.
Clinical Microbiology Reviews (2003)
Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
Mark H. Einstein;Mira Baron;Myron J. Levin;Archana Chatterjee.
Human Vaccines (2009)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe;Peter A. Leone;David I. Bernstein;Anna Wald.
The New England Journal of Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Colorado Anschutz Medical Campus
University of California, San Diego
Duke University
University of Sydney
Columbia University
University of California, Los Angeles
Health Sciences North
Beth Israel Deaconess Medical Center
Tampere University
City Of Hope National Medical Center
Sapienza University of Rome
Toyota Motor Corporation (Japan)
Federal University of Toulouse Midi-Pyrénées
University of Florida
University of Wisconsin–Madison
University of Washington
Texas A&M University
University of Urbino
University College Dublin
Korea University
University of Padua
Pohang University of Science and Technology
University of Rochester
Stanford University
Harvard University
Yale University